"It’s unlikely to see a ph2!"... which is why they are collecting so much efficacy data in ph1 and running so many patients through the trial. They don't need 100 patients simply to measure safety, but those numbers are good for a ph1 that is effectively doubling as a ph2.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy
Ann: Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy, page-94
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1925982 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 3452098 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1925982 | 0.048 |
44 | 6409183 | 0.047 |
52 | 5062868 | 0.046 |
58 | 6807888 | 0.045 |
13 | 2613180 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 3452098 | 12 |
0.050 | 3513781 | 16 |
0.051 | 7159676 | 14 |
0.052 | 2071350 | 7 |
0.053 | 818882 | 6 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |